.

GenVec Lawsuit Dismissed

Shareholders accused the Gaithersburg-based biotech of misleading investors about pancreatic cancer drug.
Shareholders accused the Gaithersburg-based biotech of misleading investors about pancreatic cancer drug.

A federal judge on Friday dismissed a lawsuit that accused a Gaithersburg-based GenVec Inc. of misleading investors about a pancreatic cancer drug, The Washington Business Journal reports.

The class-action lawsuit was filed last year and claimed that GenVec executives overstated the success of TNFerade, causing the company’s stock to trade artificially highBut the drug failed in later trials, prompting GenVec to end the program and causing its stock to drop, The Business Journal reports.

U.S. District Court Judge Deborah Chasanow said the complaint—which was more than 150 pages—failed to show that GenVec did anything illegal, The Business Journal reports.

>>>See:Shareholder Suit Against GenVec Dismissed” at BizJournals.com.

Earlier this month, GenVec announced it was backing off plans to dissolve and named a new CEO, Patch has reported

Douglas J. Swirsky—the company’s senior vice president and chief financial officer since 2006—was named chief executive officer. Cynthia Collins resigned her position as CEO.

Boards

More »
Got a question? Something on your mind? Talk to your community, directly.
Note Article
Just a short thought to get the word out quickly about anything in your neighborhood.
Share something with your neighbors.What's on your mind?What's on your mind?Make an announcement, speak your mind, or sell somethingPost something
See more »